Written by: Tommy Spain, MD, MPH
Associate Professor UT Southwestern
Children’s Medical Center Dallas
You are a pediatric pain management physician at a tertiary care pediatric hospital. Due to the overwhelming number of pediatric patients presenting to your hospital system complaining of headaches, you and your team have been asked to help the neurologists with the patient load. You have been seeing a 17 y/o female patient for the last three years for migraine headaches. She has been treated with numerous different preventives including topiramate, zonisamide, and nortriptyline with limited efficacy. She is interested in trying Aimovig (erenumab).
Which of the following is NOT true:
